Research Corporation Technologies

About The Fund

Research Corporation Technologies (RCT) is a private equity firm with a focus on advancing technology innovations within the biotechnology, medical device, therapeutic, and life science sectors. Situated at Manfield House, 1 Southampton Street, London, WC2R 0LR, United Kingdom, their investment strategy emphasizes providing venture capital to early-stage companies that are developing technologies with the potential to transform biomedical product markets. They are actively engaged in creating partnerships with entrepreneurs, founders, innovators, and inventors to foster the advancement from concept to patent, and ultimately to commercialization of cutting-edge life sciences inventions. RCT is known for their expertise in the field of equity investments, particularly in expansion, management buyouts (MBO), and leveraged buyouts (LBO). As part of their investment approach, RCT nurtures the portfolio companies with not only funding but also invaluable experience and expertise. They have established a Ventures program through which they support startups and early-stage companies that possess unique biomedical technologies with a clear competitive advantage. Moreover, RCT is involved in the development and investment in technologies that enhance the discovery and manufacture of therapeutics and diagnostics. Through affordable nonexclusive licensing, they make these life science tools accessible, promoting further research and development in the field. RCT's ability to license groundbreaking biomedical technologies to industry helps to accelerate their commercialization and facilitates access to innovative healthcare solutions. Their initiatives such as the MedTech Innovator competition further demonstrate their commitment to fostering innovation within the medical technology space.